Effects of Open-label vs Double-blind Treatment in IBS

N/ACompletedNCT02802241

Beth Israel Deaconess Medical Center340 enrolled

Overview

The purpose of this study is to investigate placebo effects and peppermint oil in Irritable Bowel Syndrome.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Enrollment

340

peppermint oilDIETARY_SUPPLEMENT

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Meet Rome IV diagnostic criteria for IBS

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Change in Irritable Bowel Syndrome - Symptom Severity Score (IBS-SSS) From Baseline to Six Weeks.

Score ranges from 0-500, 0 indicates no symptoms, 500 indicates worst possible symptoms

Time frame: 6 weeks

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.